PHBBF vs VRTX: Which Stock is Better?
Side-by-side comparison of Pharmaron Beijing Co., Ltd. and Vertex Pharmaceuticals Inc in 2026
PHBBF
Pharmaron Beijing Co., Ltd.
$1.93
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | PHBBF | VRTX | Winner |
|---|---|---|---|
| Market Cap | $3.55B | $112.22B | VRTX |
| P/E Ratio | 16.08 | 28.82 | PHBBF |
| EPS (TTM) | $0.12 | $15.31 | VRTX |
| Revenue Growth | 0.2% | 0.1% | PHBBF |
| Gross Margin | 34.7% | 53.7% | VRTX |
Analyze PHBBF
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHBBF or VRTX a better investment?
Comparing PHBBF and VRTX: Pharmaron Beijing Co., Ltd. has a market cap of $3.55B while Vertex Pharmaceuticals Inc has $112.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHBBF and VRTX?
PHBBF (Pharmaron Beijing Co., Ltd.) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHBBF or VRTX?
Based on P/E ratios, PHBBF trades at a lower multiple (16.1x vs 28.8x).
Which is growing faster: PHBBF or VRTX?
PHBBF has higher revenue growth at 0.2% vs 0.1% for VRTX.
Which company is more profitable: PHBBF or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 34.7% for PHBBF.
Which is the larger company: PHBBF or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.22B compared to $3.55B for PHBBF.
Should I buy PHBBF or VRTX in 2026?
Both PHBBF and VRTX have investment merit. PHBBF trades at $1.93 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHBBF and VRTX stock?
Key differences: Market Cap ($3.55B vs $112.22B), P/E Ratio (16.1x vs 28.8x), Revenue Growth (0.2% vs 0.1%), Gross Margin (34.7% vs 53.7%).